Spinal Cord Stimulator Market Highlights

Spinal cord stimulator is an implantable neuromodulation device used for the treatment of certain pain conditions. The device functions by sending electric signals to the areas of the spinal cord that are in pain.

Spinal Cord Stimulator Market Overview and Analysis by technology type, application, end-user and region - forecast till 2030. According to MRFR analysis, Global Spinal Cord Stimulator Market size is expected to reach USD 4.1 billion by 2030 at 8.8% CAGR during the forecast period. 

The growth of the global spinal cord stimulator market can be attributed to the rising prevalence of degenerative disc disease, increasing R&D expenditure by companies to develop innovative cord stimulators, growing geriatric population, and rising technological advancements. For instance, technology has resulted in reduced cost of the final product for end-user while increasing the capabilities of the system. Technological advancement in spinal cord stimulation (SCS) represent some of the most developments in pain management. Additional developments in this field include high-frequency spinal cord stimulation (SCS), a novel spinal cord stimulation (SCS) system that permits a pulse rate up to 10 kHz with more effective anatomic positioning, providing paraesthesia-free pain relief; percutaneous leads and paddles, which permit tailored stimulation patterns for patients with chronic pain.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region is held the largest market in 2018 owing to the rising prevalence of degenerative disc disease and the increasing adoption of technologically advanced products in the region. The spinal cord stimulator market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. For instance, market players like FDA approved Medtronic devices, the company holds up to 38% of the US market, according to recent studies.

The European spinal cord stimulator market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The spinal cord stimulator market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

Due to the increasing number of patients suffering from chronic & neuropathic pain and a growing geriatric population, the market in Asia-Pacific is expected to be the fastest-growing. The spinal cord stimulator market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The Global Spinal Cord Stimulator Market has been segmented based on Technology Type Application, and End User.

Based on the technology type, the global spinal cord stimulator market has been segmented into a conventional implantable pulse generator, rechargeable implantable pulse generator, and radiofrequency stimulator. The conventional implantable pulse generator (IPG) segment held the largest market share in 2018 owing to its high preferred type by hospitals, and excellent in long-term relief in 60%-80% patients suffering from chronic pain.

The global spinal cord stimulator market, based on application, has been segmented into failed back surgery syndrome, complex regional pain syndrome, arachnoiditis, sciatica, degenerative disc disease and others. The failed back surgery syndrome (FBSS) segment held the largest market share in 2018 due to the increasing prevalence of failed back surgery syndrome (FBSS) worldwide.

The market based on end-user has been segmented into hospitals & clinics, ambulatory surgical centres, and others. Hospitals & clinics segment held the largest market share in 2018 owing to the rising in visits of patients.

Market Players

The global spinal cord stimulator market players are Boston Scientific Corporation (US), Abbott (US), Nevro Corp. (US), Medtronic (Ireland), Stimwave LLC (US), Nuvectra (US), Beijing PINS Medical Co., Ltd (China), Cirtec (US), NeuroSigma, Inc. (US), Synapse Biomedical Inc. (US), and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com